Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08LVT
|
||||
| Former ID |
DNC006202
|
||||
| Drug Name |
4-hydroxy-N-neopentyl-N-phenylbenzenesulfonamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527880] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C17H21NO3S
|
||||
| Canonical SMILES |
CC(C)(C)CN(C1=CC=CC=C1)S(=O)(=O)C2=CC=C(C=C2)O
|
||||
| InChI |
1S/C17H21NO3S/c1-17(2,3)13-18(14-7-5-4-6-8-14)22(20,21)16-11-9-15(19)10-12-16/h4-12,19H,13H2,1-3H3
|
||||
| InChIKey |
QKNCIALYEAWCOU-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor | Target Info | Inhibitor | [527880] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| Plasma membrane estrogen receptor signaling | |||||
| LKB1 signaling events | |||||
| Regulation of Telomerase | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| FOXM1 transcription factor network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| FOXA1 transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.